GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 320 filers reported holding GW PHARMACEUTICALS PLC in Q4 2019. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $76,370,000 | +326.6% | 352,100 | +127.0% | 0.10% | +400.0% |
Q4 2020 | $17,900,000 | +113.6% | 155,103 | +80.1% | 0.02% | +137.5% |
Q3 2020 | $8,382,000 | -68.0% | 86,102 | -65.6% | 0.01% | -60.0% |
Q4 2019 | $26,158,000 | -24.2% | 250,171 | -16.6% | 0.02% | -31.0% |
Q3 2019 | $34,509,000 | +1118.1% | 300,000 | +1729.3% | 0.03% | +866.7% |
Q3 2018 | $2,833,000 | -81.0% | 16,400 | -84.6% | 0.00% | -62.5% |
Q2 2018 | $14,903,000 | +571.3% | 106,800 | +535.0% | 0.01% | +300.0% |
Q4 2017 | $2,220,000 | -73.6% | 16,820 | -80.0% | 0.00% | -81.8% |
Q2 2017 | $8,421,000 | -22.8% | 84,000 | -6.9% | 0.01% | -26.7% |
Q1 2017 | $10,909,000 | -15.7% | 90,200 | -49.7% | 0.02% | -40.0% |
Q1 2016 | $12,944,000 | +23.2% | 179,400 | +18.6% | 0.02% | +8.7% |
Q4 2015 | $10,506,000 | +995.5% | 151,300 | +1341.0% | 0.02% | +1050.0% |
Q3 2015 | $959,000 | +352.4% | 10,500 | +105.9% | 0.00% | +100.0% |
Q4 2013 | $212,000 | – | 5,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Copernicus Capital Management, LLC | 52,488 | $5,110,000 | 4.87% |
GREAT POINT PARTNERS LLC | 520,232 | $50,645,000 | 4.56% |
Integral Health Asset Management, LLC | 65,000 | $6,328,000 | 1.94% |
CLOUGH CAPITAL PARTNERS L P | 190,716 | $18,566,000 | 1.34% |
Parkman Healthcare Partners LLC | 50,000 | $4,868,000 | 1.29% |
ETF MANAGERS GROUP, LLC | 375,344 | $36,540,000 | 1.16% |
Redwood Investments, LLC | 124,094 | $12,081,000 | 1.02% |
Eventide Asset Management | 436,000 | $42,445,000 | 0.83% |
Bellevue Group AG | 562,943 | $54,803,000 | 0.76% |
ROOSEVELT INVESTMENT GROUP LLC | 95,499 | $9,297,000 | 0.75% |